BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 8955050)

  • 1. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His).
    Li Y; Zhang Z; Kang SM; Buescher JL; Morrow CD
    Virology; 1997 Nov; 238(2):273-82. PubMed ID: 9400600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His).
    Li Y; Zhang Z; Wakefield JK; Kang SM; Morrow CD
    J Virol; 1997 Sep; 71(9):6315-22. PubMed ID: 9261348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription.
    Zhang Z; Kang SM; Li Y; Morrow CD
    RNA; 1998 Apr; 4(4):394-406. PubMed ID: 9630246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met).
    Kang SM; Zhang Z; Morrow CD
    J Virol; 1997 Jan; 71(1):207-17. PubMed ID: 8985340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a human immunodeficiency virus type 1 that stably uses tRNALys1,2 rather than tRNALys,3 for initiation of reverse transcription.
    Kang SM; Zhang Z; Morrow CD
    Virology; 1999 Apr; 257(1):95-105. PubMed ID: 10208924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
    Wakefield JK; Kang SM; Morrow CD
    J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementarity between 3' terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription.
    Yu Q; Morrow CD
    Virology; 1999 Feb; 254(1):160-8. PubMed ID: 9927583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic evidence of the interaction between tRNA(Lys,3) and U5 facilitating efficient initiation of reverse transcription by human immunodeficiency virus type 1.
    Zhang Z; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):979-88. PubMed ID: 9686644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations within the primer binding site of the human immunodeficiency virus type 1 define sequence requirements essential for reverse transcription.
    Wakefield JK; Morrow CD
    Virology; 1996 Jun; 220(2):290-8. PubMed ID: 8661380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of a unique human immunodeficiency virus type 1 (HIV-1) with a primer binding site complementary to tRNAMet supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcription.
    Kang SM; Morrow CD
    J Virol; 1999 Mar; 73(3):1818-27. PubMed ID: 9971759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of HIV type 1 proviral genomes that contain two distinct primer-binding sites.
    Li Y; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):253-62. PubMed ID: 9115813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin.
    Laughrea M; Shen N; Jetté L; Darlix JL; Kleiman L; Wainberg MA
    Virology; 2001 Mar; 281(1):109-16. PubMed ID: 11222101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer.
    Rigourd M; Goldschmidt V; Brulé F; Morrow CD; Ehresmann B; Ehresmann C; Marquet R
    Nucleic Acids Res; 2003 Oct; 31(19):5764-75. PubMed ID: 14500840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1 that select tRNA(His) or tRNA(Lys1,2) as primers for reverse transcription exhibit different infectivities in peripheral blood mononuclear cells.
    Moore KL; Kosloff BR; Kelly NJ; Kirkman RL; Dupuy LC; McPherson S; Morrow CD
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):373-81. PubMed ID: 15157356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
    Wakefield JK; Rhim H; Morrow CD
    J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.